Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.
about
Parenteral versus enteral nutrition: effect on serum cytokines and the hepatic expression of mRNA of suppressor of cytokine signaling proteins, insulin-like growth factor-1 and the growth hormone receptor in rodent sepsisHip fracture patients, a group of frail elderly people with low bone mineral density, muscle mass and IGF-I levels.Dangers of growth hormone therapy in critically ill patients.Growth hormone: current and future therapeutic applications.Significance of transthyretin in protein metabolism.Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidenceInsulin-like growth factor I response during nutritional rehabilitation of persistent diarrhoea.Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients.The roles of insulin and hyperglycemia in sepsis pathogenesis.Endocrine modifications and interventions during critical illness.Effect of tight glucose control with insulin on the thyroid axis of critically ill children and its relation with outcomeHepatic growth hormone resistance after acute injury.Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsisInterleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.Pituitary dysfunction in traumatic brain injury: Is evaluation in the acute phase worthwhile?Interaction of the endocrine system with inflammation: a function of energy and volume regulation.Parenteral nutrition in adult intensive care.On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments.Biochemical investigations in diagnosis and follow up of acromegaly.The insulin-like growth factors in critical illness: pathophysiology and therapeutic potential.Relationships among magnetic resonance imaging, histological findings, and IGF-I in steroid-induced osteonecrosis of the femoral head in rabbits.Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation.Avoiding autocannibalism.Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness.Somatotropic and thyroid hormones in the acute phase of subarachnoid haemorrhage.Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients.Neuroendocrine dysfunction in acute phase of moderate-to-severe traumatic brain injury: a prospective study.Prospective investigation of anterior pituitary function in the acute phase and 12 months after pediatric traumatic brain injury.Monthly measurements of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in healthy prepubertal children: characterization and relationship with growth: the 1-year growth study.Serum thyroid hormones levels are significantly decreased in septic neonates with poor outcome.Outcome of Critically ill Patients Undergoing Mandatory Insulin Therapy Compared to Usual Care Insulin Therapy: Protocol for a Pilot Randomized Controlled Trial.Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns?Evaluation of endocrine function in children admitted to pediatric intensive care unit
P2860
Q28569713-DD122B74-237D-409C-9F15-15AE265F1DD1Q33815730-3AEA5EF2-F807-4A24-8A71-39AD89DDEC45Q34008364-6CC9C361-E3A8-42CE-A758-C75480E974AAQ34182027-F7521EC5-B0D9-4AEE-8A33-EB64B392CB97Q35054946-823C12CF-44A8-4B9E-8660-6A8FBBA66CBAQ35099084-A9FFBF4A-B7FE-486D-8E00-128105F418B3Q35263299-19823F83-AB78-42ED-9C3A-4FFA1C9918C2Q35274557-456A1DD3-DCDD-4435-8F43-4FA7B879FAFCQ35600806-908E3D55-7496-48BA-A3D6-0FC92E388F44Q35890474-14B0AEEE-9FD3-4752-8B9B-6C7C6E1280E4Q36293600-A68B40F1-664B-4818-AB11-E79651F84975Q36699521-5EB4FA0B-133E-455D-A193-CCD8173B3CAFQ37206724-29F06FFC-08E5-46EA-83CC-F0ACACFC04B3Q37363276-136AEDAA-0230-4498-B1D7-371455C544ABQ37588878-E84D3AEB-5CB6-42A3-8B82-F4B77247499DQ37690138-A34836CB-26CF-453F-8C33-EA4EB43052C4Q38663678-B7CC9ACD-D5BA-4D04-B7B3-E08B57DFA7E0Q38822905-3471F725-AB33-429A-9BA8-F066F531938FQ39123579-9B01A96D-0602-4DAE-BC5A-FE751B658970Q40924772-11EC0C4C-52C0-4902-A78B-220C4F7DE69BQ42426366-93BFB600-0496-41EB-A84C-964BECD5B4F3Q42438472-B08348FD-9DF7-4F4E-8D78-F4D48FDD0CBAQ43162069-4B209F45-4C07-423E-822F-A364C0DA8437Q44448751-53F6AD7E-4548-4FEB-980E-A938A57F476DQ45208149-33AA7686-FBCE-4983-ADD8-CF0B37FCA801Q47281990-AE1082A3-7F87-4E8A-98E5-2116047CAF85Q48049831-D3DD9481-7F8D-4274-AD6E-3674AF29EAC5Q48811927-046B13DF-CAF3-4445-9F0D-9B3C9F4113B8Q50639391-0F029AC8-1ECA-421D-B69A-EC36B1C14C05Q51752315-61B04E86-55A4-4E83-86A5-096FF27D3C13Q52665851-8352C593-DFC4-4C68-8C45-864F95989BBAQ53974510-70002F50-C7D8-4DEF-8BBA-35BF70EE23CAQ57816495-B5881445-8CF5-4E19-B9E4-634525B5B8D5
P2860
Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Critically ill patients have h ...... insulin-like growth factor-I.
@en
type
label
Critically ill patients have h ...... insulin-like growth factor-I.
@en
prefLabel
Critically ill patients have h ...... insulin-like growth factor-I.
@en
P2093
P2860
P1476
Critically ill patients have h ...... insulin-like growth factor-I.
@en
P2093
Buchanan C
Matthews D
P2860
P356
10.1111/J.1365-2265.1991.TB03495.X
P577
1991-07-01T00:00:00Z